1,2-dimethylhydrazine and exenatide

1,2-dimethylhydrazine has been researched along with exenatide in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hansen, LS; Hare, KJ; Hartmann, B; Holst, JJ; Kissow, H; Poulsen, SS; Rosenkilde, MM; Viby, NE	1
Mohamed, MI; Tawfik, MK	1

Other Studies

2 other study(ies) available for 1,2-dimethylhydrazine and exenatide

Article	Year
Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice. Regulatory peptides, 2012, Nov-10, Volume: 179, Issue:1-3 Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Adenoma; Anatomy, Cross-Sectional; Animals; Chlorocebus aethiops; Colon; Colonic Neoplasms; COS Cells; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptide-2 Receptor; Hypoglycemic Agents; Intestinal Mucosa; Intestine, Small; Liraglutide; Mice; Mice, Inbred C57BL; Organ Size; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Transfection; Triazoles; Venoms	2012
Exenatide suppresses 1,2-dimethylhydrazine-induced colon cancer in diabetic mice: Effect on tumor angiogenesis and cell proliferation. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 82 Topics: 1,2-Dimethylhydrazine; Animals; Antigens, CD34; Body Weight; Cell Proliferation; Cisplatin; Colon; Colonic Neoplasms; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Exenatide; Gene Expression Regulation, Neoplastic; Interleukin-6; Ki-67 Antigen; Male; Mice; Neovascularization, Pathologic; Peptides; RNA, Messenger; Survival Analysis; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Venoms	2016

Article

Year

Glucagon-like peptide-1 (GLP-1) receptor agonism or DPP-4 inhibition does not accelerate neoplasia in carcinogen treated mice.

Regulatory peptides, 2012, Nov-10, Volume: 179, Issue:1-3

Topics: 1,2-Dimethylhydrazine; Aberrant Crypt Foci; Adenoma; Anatomy, Cross-Sectional; Animals; Chlorocebus aethiops; Colon; Colonic Neoplasms; COS Cells; Cyclic AMP; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Exenatide; Female; Glucagon-Like Peptide 1; Glucagon-Like Peptide-1 Receptor; Glucagon-Like Peptide-2 Receptor; Hypoglycemic Agents; Intestinal Mucosa; Intestine, Small; Liraglutide; Mice; Mice, Inbred C57BL; Organ Size; Peptides; Pyrazines; Receptors, Glucagon; Sitagliptin Phosphate; Transfection; Triazoles; Venoms

2012

Exenatide suppresses 1,2-dimethylhydrazine-induced colon cancer in diabetic mice: Effect on tumor angiogenesis and cell proliferation.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 82

Topics: 1,2-Dimethylhydrazine; Animals; Antigens, CD34; Body Weight; Cell Proliferation; Cisplatin; Colon; Colonic Neoplasms; Cyclooxygenase 2; Diabetes Mellitus, Experimental; Exenatide; Gene Expression Regulation, Neoplastic; Interleukin-6; Ki-67 Antigen; Male; Mice; Neovascularization, Pathologic; Peptides; RNA, Messenger; Survival Analysis; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2; Venoms

2016